Group One Trading’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-162,227
| Closed | -$649K | – | 6097 |
|
|
2019
Q4 | $649K | Buy |
162,227
+127,695
| +370% | +$600K | ﹤0.01% | 2226 |
|
|
2019
Q3 | $169K | Sell |
34,532
-9,131
| -21% | -$51.1K | ﹤0.01% | 3207 |
|
|
2019
Q2 | $266K | Sell |
43,663
-818
| -2% | -$4.35K | ﹤0.01% | 2646 |
|
|
2019
Q1 | $258K | Buy |
44,481
+40,074
| +909% | +$414K | ﹤0.01% | 2512 |
|
|
2018
Q4 | $59K | Buy |
4,407
+1,581
| +56% | +$26.7K | ﹤0.01% | 3470 |
|
|
2018
Q3 | $55K | Buy |
2,826
+2,395
| +556% | +$51K | ﹤0.01% | 3927 |
|
|
2018
Q2 | $11K | Sell |
431
-1,504
| -78% | -$35.1K | ﹤0.01% | 4604 |
|
|
2018
Q1 | $39K | Buy |
1,935
+173
| +10% | +$4.04K | ﹤0.01% | 3774 |
|
|
2017
Q4 | $35K | Sell |
1,762
-288
| -14% | -$5.66K | ﹤0.01% | 3912 |
|
|
2017
Q3 | $42K | Sell |
2,050
-1,700
| -45% | -$28.7K | ﹤0.01% | 3731 |
|
|
2017
Q2 | $56K | Buy |
3,750
+1,800
| +92% | +$30K | ﹤0.01% | 3459 |
|
|
2017
Q1 | $31K | Sell |
1,950
-900
| -32% | -$13K | ﹤0.01% | 3682 |
|
|
2016
Q4 | $36K | Buy |
2,850
+2,450
| +613% | +$45.6K | ﹤0.01% | 3447 |
|
|
2016
Q3 | $11K | Buy |
+400
| New | +$13.4K | ﹤0.01% | 4029 |
|
|
2016
Q1 | – | Sell |
-1,068
| Closed | -$31.4K | – | 5193 |
|
|
2015
Q4 | $37K | Buy |
+1,068
| New | +$33.3K | ﹤0.01% | 3595 |
|
Other funds holding DPLO
Group One Trading's DPLO Position: Q1 2020 in Review
Group One Trading sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 162,227 shares — an estimated $649K sold.
Group One Trading first reported a position in DPLO in Q4 2015 and held it in 15 quarters. The position peaked at $649K in Q4 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Group One Trading reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Group One Trading sold 162,227 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $649K.
- Group One Trading first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 15 quarters.
- Group One Trading's DIPLOMAT PHARMACY, INC. position peaked at $649K in Q4 2019.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Group One Trading's 13F filing for Q1 2020, filed 13 May 2020.